Rebecca Silvia Mcdonald

• Welle-Strand, Gabrielle Katrine; Pierron, Marianne; Olsen, Ida Kristine; Bjørnestad, Ronny & Mcdonald, Rebecca Silvia (2024). “Life feels better with the right medication”. Results from a service user organization-led survey of opioid maintenance treatment patients in Norway. Heroin Addiction and Related Clinical Problems. ISSN 1592-1638. 26(1). doi: 10.62401/2531-4122-2024-19.
• Metrebian, Nicola; Carter, Ben; Eide, Desiree; Mcdonald, Rebecca Silvia; Neale, Joanne & Parkin, Stephen [Vis alle 16 forfattere av denne artikkelen] (2023). A study protocol for a European, mixed methods, prospective, cohort study of the effectiveness of naloxone administration by community members, in reversing opioid overdose: NalPORS. BMC Public Health. ISSN 1471-2458. 23(1). doi: 10.1186/s12889-023-16445-6. Fulltekst i vitenarkiv
• Carver, Hannah; Ciolompea, Teodora; Conway, Anna; Kilian, Carolin; Mcdonald, Rebecca Silvia & Meksi, Andia [Vis alle 7 forfattere av denne artikkelen] (2023). Substance use disorders and COVID-19: reflections on international research and practice changes during the “poly-crisis”. Frontiers in Public Health. ISSN 2296-2565. 11. doi: 10.3389/fpubh.2023.1201967. Fulltekst i vitenarkiv
• Eide, Desiree; Mcdonald, Rebecca Silvia; Hamina, Aleksi; Clausen, Thomas; Odsbu, Ingvild & Skurtveit, Svetlana Ondrasova (2023). Prescription high-risk polysubstance use among opioid maintenance treatment patients. International journal of drug policy. ISSN 0955-3959. doi: 10.1016/j.drugpo.2023.104196. Fulltekst i vitenarkiv
• Mcdonald, Rebecca Silvia; Bech, Anne Berit & Clausen, Thomas (2023). Flexible delivery of opioid agonist treatment during COVID-19 in Norway: qualitative and quantitative findings from an online survey of provider experiences. BMC Health Services Research. ISSN 1472-6963. 23(1). doi: 10.1186/s12913-023-09959-7. Fulltekst i vitenarkiv Vis sammendrag

  Background For patients receiving daily opioid agonist treatment (OAT) for opioid dependence, several countries relaxed treatment guidelines at the beginning of the COVID-19 pandemic. This involved longer take-home intervals for methadone and buprenorphine doses as well as a reduction in supervised dosing and drug screening. To date, little is known about the medium or long-term experience of OAT deregulation. Therefore, we conducted a survey to explore how OAT providers perceived greater flexibility in OAT service delivery at the end of the second year of the pandemic. Methods Nationwide cross-sectional study of twenty-three OAT units in 19 publicly funded hospital trusts in Norway. OAT units were sent a 29-item online questionnaire comprising closed-format and open-ended questions on treatment provider experiences and changes in OAT service delivery during the past 12 months (January to December 2021). Results Twenty-three (of whom female: 14; 60.8%) managers or lead physicians of OAT units completed the questionnaire reporting that, in 2021, most OAT units (91.3%, n = 21) still practiced some adjusted approaches as established in the beginning of the pandemic. The most common adaptions were special protocols for COVID-19 cases (95.7%, n = 22), increased use of telephone- (91.3%, n = 21) and video consultations (87.0%, n = 20), and longer take-home intervals for OAT medications (52.2%, n = 12). The use of depot buprenorphine also increased substantially during the pandemic. According to the OAT providers, most patients handled flexible treatment provision well. In individual cases, patients’ substance use was identified as key factor necessitating a reintroduction of supervised dosing and drug screening. Collaboration with general practitioners and municipal health and social services was generally perceived as crucial for successful treatment delivery. Conclusions Overall, the Norwegian OAT system proved resilient in the second year of the COVID-19 pandemic, as its healthcare workforce embraced innovation in technology (telemedicine) and drug development (depot buprenorphine). According to our nationally representative sample of OAT providers, most patients were compliant with longer take-home doses of methadone and buprenorphine. Our findings suggest that telemedicine can be useful as adjunct to face-to-face treatment and provide greater flexibility for patients.

• Ebrahimian, Melika; Zamani, Nasim; Dolat Abadi, Sahel Shafiee; Gheisari, Mehdi; Mcdonald, Rebecca Silvia & Hassanian-Moghaddam, Hossein (2023). Dermatologic features of chronic intramuscular use of ketamine: a case report. Forensic Science, Medicine, and Pathology. ISSN 1547-769X. 19(1), s. 129–132. doi: 10.1007/s12024-023-00580-y.
• Rafizadeh, Ali; Bhalla, Ashish; Sharma, Neha; Kumar, Kuldeep; Zamani, Nasim & Mcdonald, Rebecca Silvia [Vis alle 8 forfattere av denne artikkelen] (2022). Evaluating new simplified assays for harm reduction from methanol poisoning using chromotropic acid kits: An analytical study on Indian and Iranian alcoholic beverages. Frontiers in Public Health. ISSN 2296-2565. 10. doi: 10.3389/fpubh.2022.983663. Fulltekst i vitenarkiv
• Hadeiy, Seyed Kaveh; Zamani, Nasim; Mcdonald, Rebecca Silvia; Rezaei, Omidvar; Kolahi, Ali-Asghar & Gholami, Narges [Vis alle 8 forfattere av denne artikkelen] (2022). An interrupted time series analysis of hospital admissions due to alcohol intoxication during the COVID‐19 pandemic in Tehran, Iran. Scientific Reports. ISSN 2045-2322. 12(1). doi: 10.1038/s41598-022-14799-2. Fulltekst i vitenarkiv
• Mahdavi, Seyed Amirhosein; Zamani, Nasim; Mcdonald, Rebecca Silvia; Akhgari, Maryam; Kolahi, Ali-Asghar & Gheshlaghi, Farzad [Vis alle 30 forfattere av denne artikkelen] (2022). A cross-sectional multicenter linkage study of hospital admissions and mortality due to methanol poisoning in Iranian adults during the COVID-19 pandemic. Scientific Reports. ISSN 2045-2322. 12(1). doi: 10.1038/s41598-022-14007-1. Fulltekst i vitenarkiv
• Hadeiy, Seyed Kaveh; Gholami, Narges; Mcdonald, Rebecca Silvia; Rezaei, Omidvar; Kolahi, Ali-Asghar & Zamani, Nasim [Vis alle 10 forfattere av denne artikkelen] (2022). Hospital-treated intentional self-poisoning events and in-hospital mortality in Tehran before and during the COVID-19 pandemic. Current Psychology. ISSN 1046-1310. doi: 10.1007/s12144-022-03248-y.
• Mcdonald, Rebecca Silvia; Eide, Desiree; Abel-Ollo, Katri; Barnsdale, Lee; Carter, Ben & Clausen, Thomas [Vis alle 24 forfattere av denne artikkelen] (2022). A rapid assessment of take-home naloxone provision during COVID-19 in Europe. International journal of drug policy. ISSN 0955-3959. 107. doi: 10.1016/j.drugpo.2022.103787. Fulltekst i vitenarkiv

Se alle arbeider i Cristin

• Mcdonald, Rebecca Silvia (2024). Prescription High-Risk Polysubstance Use Among OST Patients and Implications for Clinical Practice.
• Mcdonald, Rebecca Silvia; Eide, Desiree; Skurtveit, Svetlana Ondrasova & Clausen, Thomas (2024). Pills and the damage done: the opioid epidemic as man-made crisis. Frontiers in Public Health. ISSN 2296-2565. 11. doi: 10.3389/fpubh.2023.1241404.
• Mcdonald, Rebecca Silvia (2023). Differences between individuals dying of intentional versus accidental overdoses: A population-based register study.
• Nesse, Linda; Mcdonald, Rebecca Silvia; Bech, Anne Berit & Clausen, Thomas (2023). Medborgerskap: Et perspektiv for brukermedvirkning i LAR. Rus & samfunn. ISSN 1500-8614.
• Bech, Anne Berit; Clausen, Thomas & Mcdonald, Rebecca Silvia (2022). Revised service delivery of opioid agonist treatment in Norway in 2021, the second year of the pandemic: a national cross-sectional study of treatment provider experiences.
• Mcdonald, Rebecca Silvia & Clausen, Thomas (2022). Revised service delivery of opioid agonist treatment in Norway in 2021, the second year of the pandemic: a national cross-sectional study of treatment provider experiences.
• Gholami, Narges; Mcdonald, Rebecca Silvia; Zamani, Nasim & Hassanian-Moghaddam, Hossein (2022). Comment on: predictors of severe outcome following opioid intoxication in children. Clinical Toxicology. ISSN 1556-3650. doi: 10.1080/15563650.2022.2075375.

Se alle arbeider i Cristin